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Abstract 
 
The demand for improved technologies capable of rapidly detecting pathogens with high sensitivity and 
selectivity in complex environments continues to be a significant challenge that helps drive the 
development of new analytical techniques. Surface-based detection platforms are particularly attractive as 
multiple bioaffinity interactions between different targets and corresponding probe molecules can be 
monitored simultaneously in a single measurement. Furthermore, the possibilities for developing new 
signal transduction mechanisms alongside novel signal amplification strategies are much more varied. In 
this article, we describe some of the latest advances in the use of surface bioaffinity detection of 
pathogens. Three major sections will be discussed: (i) a brief overview on the choice of probe molecules 
such as antibodies, proteins and aptamers specific to pathogens and surface attachment chemistries to 
immobilize those probes onto various substrates, (ii) highlighting examples among the current generation 
of surface biosensors, and (iii) exploring emerging technologies that are highly promising and likely to 
form the basis of the next generation of pathogenic sensors. 
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Introduction 
Rapid and simple detection of pathogenic species continues to be an important research objective 
of immense significance for human health, prosperity and security. For example, fungal plant 
pathogens can result in large crop losses and the clandestine production and use of toxins 
produced by such pathogens is considered an ever present biothreat. This requires the monitoring 
of crops, food and water supplies as well as airborne contamination. Despite significant progress 
made in recent years in the environmental surveillance of harmful agents, the potential to inflict 
enormous damage to a nation’s economy and security remains a strong driving force to develop 
robust, fieldable biosensors which shorten the time span between sample collection and results 
without compromising accuracy or sensitivity.  
 
There are a number of well-established laboratory-based approaches for pathogen detection. 
Culture and colony counting[1] is the oldest bacterial analysis technique and continues to be a 
standard method that provides unambiguous results. However, culturing often requires up to 
several days depending on the microbe type thus making other techniques necessary. Molecular 
identification approaches are primarily based on the detection of specific nucleotide sequences 
within the pathogen genome or the detection of pathogen-specific protein molecules or epitopes 
on the cell surface using antibodies. The most widely used methods are based on various 
polymerase chain reaction (PCR) formats or enzyme-linked immunosorbent assays (ELISA). 
Even though both these solution-based approaches can be highly specific and sensitive, 
especially PCR, they often require the time-consuming extraction and purification of nucleic 
acids or antigens from samples. Other issues include contamination control and discriminating 
false positive and negative results. In addition, these assays are label-dependent involving the use 
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of reporter molecules conjugated to either an enzyme or fluorescent probe as well as having very 
limited capabilities for the simultaneous investigation of multiple targets in a single sample 
aliquot.   
 
These limitations, among others, have promoted the exploration of a large variety of alternative 
biosensing technologies in recent years (see Figure 1). Of particular interest are surface 
bioaffinity sensors capable of direct detection. By direct we mean the detection of species 
without the need for prior chemical and/or enzymatic manipulation of the target sample prior to 
analysis. This can be achieved in a “label-free” format where the specific binding of a target onto 
a surface immobilized probe molecule is usually measured via a change in properties such as 
refractive index or mass. For targets with more than one epitope, a second labeled bioaffinity 
probe can be subsequently introduced to further amplify the detection signal. The challenge is to 
create pathogen sensing methodologies that efficient, highly robust and can be integrated into 
portable devices for on-site analysis without compromising sensitivity or specificity. 
Furthermore, the ability to handle complex samples with minimum or no preparation required 
beforehand is also highly desirable.   
 
It is not the intention of this review to comprehensively discuss each reported approach that has 
emerged in recent years. Instead, our main focus is the manner in which the presence of the 
target is transduced (i.e. optical, electronic and mechanical) and the associated detection platform. 
However, an overview would not be complete without at least a brief discussion on surface 
chemistry. The remainder of the article is then composed of a further two sections with the first 
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discussing examples among the current generation of surface biosensors before highlighting new 
and emerging trends that are likely to form the next generation of pathogenic sensing 
technologies.   
 
Choice of Surface Bioaffinity Ligands 
The crucial first step to consider when applying conventional bioaffinity sensing formats as well 
as emerging technologies, including nanotechnology, is the design and surface immobilization of 
ligands that have a high specificity towards a particular target species. While initial approaches 
were typically limited to identifying single pathogens, there is an increasing demand for 
multiplexed detection. DNA microarrays have emerged as a key high throughput technology for 
bacterial and viral typing and detection where hundreds to thousands of individual DNA 
sequences can be compared in a single experiment. Such analyses first involve the successful 
extraction and PCR amplification of cleaned-up samples which typically restricts their use to 
within the laboratory. The utilization of DNA microarrays and fluorescence imaging for 
pathogen analysis have been nicely reviewed elsewhere and are not discussed further[2]. 
 
At present, antibodies remain the most established ligand for the rapid surface bioaffinity 
detection of pathogens, as demonstrated by the examples discussed in following sections. The 
surface immobilization of antibodies (and proteins in general) in a stable, high-density and 
reproducible manner without subsequent loss of bioactivity has proven to be significantly more 
challenging than that for DNA. However, a variety of chemistries have been developed in recent 
years allowing immobilisation onto a wide range of senor surfaces (e.g. glass, silicon, gold, 
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plastic microwells, hydrogels, etc.)[3]. Surface attachment can occur via physiosorption onto 
polymer coated surfaces as well as covalent coupling through a cross linker via thiol, maleimide 
or amino groups and using affinity binding such as biotin/streptavidin[4]. Another issue is the 
considerable effort required to obtain antibodies that are highly specific towards a single target. 
A large number of protein and carbohydrate binding sites (epitopes) are common to various 
different species. The rational production of antibodies involves first identifying pathogen-
specific surface proteins[5]. These are then cloned and expressed in order to be used as antigens 
for antibody production. This involves a great deal of work and consequently many proof-of-
principle demonstrations of new sensing technologies focus on a relatively small number of 
antibody-pathogen interactions.    
 
These challenges have encouraged researchers to explore alternative biomolecular ligands (or 
probes) whose protein binding properties are similar to or better than those of antibodies. 
Particularly promising are nucleic acid aptamers, which are short, single-stranded RNA or DNA 
sequences (20-30 bases long) that selectively bind to non-nucleic targets such as proteins as 
well as a large variety of other targets that include toxins, cells and tissues. Binding occurs via 
interaction of the target with particular 3-D loop structures formed by the nucleic acids.  
Aptamers are typically selected from large libraries using a reiterative selection and 
amplification process known as SELEX[6]. This process combined with well-established 
methods for creating nucleic acids, their robustness and the opportunity to introduce additional 
chemical functionalities offer several advantages over antibodies. Consequently, a growing 
number of aptamers targeting specific pathogens have started to emerge in recent years[7]. In 
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another example, Sreevatsan et al. utilized DNA aptamers specific to Salmonella enteric serovars 
in PCR-based detection[8].  
 
Surface-based Pathogen Sensors in Use Today  
The new opportunities that a surface-based sensing approach provides such as greater 
multiplexing capability, enabling coupling with multi-step amplification schemes as well as 
interfacing with a variety of signal transduction mechanisms has resulted in the development of  
a wide range of surface-sensitive detection platforms. Figure 2 provides a schematic overview of 
various sensing methodologies representing the current generation of surface bioaffinity 
pathogen detection platforms and are discussed in more detail below. A more comprehensive list 
is provided in Table 1 which also includes typical examples of each technique along with the 
surface probe used and the reported detection limit.  
 
Fluorescence microscopy  
One of the most consistent challenges in performing quantitative biosensing is the requirement of 
a label to enable signal generation. This can involve directly attaching the label to the target 
pathogen itself or to a secondary or even tertiary recognition element. In a sandwich assay (see 
Figure 2a), immobilized antibodies capture the unlabeled target followed by the binding of a 
second fluorescently labeled antibody specific to a different site on the pathogen[9-12]. Recent 
examples include prototype fluorescence sensors that can measure intrinsic cellular fluorescence 
focusing on bacterial cells using hemin (ferriprotoporphyrin IX) tethered on a disposable chip 
[13], fluorescence array sensors utilizing the evanescent wave for excitation of fluorescently 
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tagged reporters in pathogen detection[14] as well as miniaturized real-time total internal 
reflection fluorescence (TIRF) array biosensors using planar waveguides created on different 
surfaces (glass, silica and polystyrene)[15]. Fluorescence-based analysis remains one of the most 
popular detection methodologies, however issues such as the additional expense of labeling, dye 
photobleaching and instrumentation costs have driven the emergence of alternative label-free 
methods. In particular, techniques with the potential for achieving the necessary sensitivity as 
well as being low-cost and portable are of especial interest to researchers developing new 
pathogen detection methods.      
 
Surface plasmon resonance (SPR)  
SPR is currently the leading technology for label-free pathogen detection. As shown in Figure 
2b, a low power light source is coupled to the interface of a thin gold film via total internal 
reflection where propagating surface plasmon modes are excited depending on the photon 
frequency and incidence angle. The plasmon resonance is highly sensitive to local changes in 
refractive index within the evanescent field at the gold/ sample solution interface and thus does 
not require the use of a label. When pathogens specifically bind to antibodies immobilized onto 
the gold surface, changes in the intensity of light reflected off the surface are measured by the 
detector. The popularity of SPR is indicated by the growing number of companies offering either 
lab-based or portable SPR instrumentation such as GE Healthcare, IBIS Technologies, GWC 
Technologies and KMAC. Currently, most measurements are still restricted to one or two 
pathogen species per sample surface although larger array-type measurements have been 
performed for nucleic acid and proteomic studies[16]. Typically between one and eight flow 
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channels are used to deliver samples and controls to the surface and the associated signal 
changes compared. For example, Irudayaraj et al. utilized SPR immunosensors for the detection 
of various pathogens in conjunction with the modulation of sensor surface using a mixed 
monolayer of polyethylene glycol (PEG) terminated alkane thiols[17-18]. Homola et al. reported 
an eight-channel SPR sensor based on wavelength division multiplexing for the simultaneous 
detection of four foodborne pathogens using target specific antibodies[19]. Another recent 
example is the highly sensitive and selective SPR detection of Bacillus anthracis in the presence 
of other related Bacillus spores via the use of a mouse  monoclonal antibody designated 8G3 
raised against the target spores[20].   
 
Higher degrees of multiplexing and sample detection throughput can be achieved using an SPR 
imaging platform where multiple ligands are immobilized in an array format with each element 
individually addressable (see Figure 3). As can be seen from the example in the Figure 3b inset, 
16 S ribosomal RNA from Escherichia coli (E coli) could easily be screened using SPR imaging 
in conjunction with DNA microarrays fabricated on a self-assembled monolayer of the amine-
terminated alkanethiol modified gold surface[21]. Homola et al. also employed a SPR imaging 
platform for the detection of foodborn pathogens[22] utilizing an array of sensing channels 
prepared by microspotting various thiolated DNA probe solutions complementary to specific 16 
S ribosomal RNAs sequences of selected pathogen targets. Furthermore, SPR sensors are readily 
amenable to incorporation into portable and/or sensing platforms for pathogen taking advantage 
of the developments in microfluidics and the fabrication of miniaturized optics[23-24]. An 
extensive list of label -free SPR based detection of pathogens can be found in Table 1. 
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Quartz crystal microbalance (QCM) 
An alternative label-free approach to pathogen detection is the use of a quartz crystal resonator 
sandwiched between two thin gold electrodes (see Figure 2c) which can be used in a liquid 
environment for biosensing. The quartz crystal oscillates at a particular resonance frequency and 
when a change in mass occurs such as due to adsorption of molecules onto the gold surface, the 
frequency decreases. Changes in oscillation damping can also be used to provide structural 
information about the thin molecular layers formed. Although QC resonators have been used for 
many years to control the vapor-phase growth of thin films it is only more recently that this 
technology has emerged as a competitor to SPR with companies such as Qsense and KSV 
Instruments providing products targeted at the biosensing market. Immunoassays can be created 
by immobilizing antibodies onto the gold surface however, unlike for SPR, measurements are 
restricted to a single target per electrode surface. In an early example, Guilbault et al. developed 
a QCM sensor for the detection of Listeria monocytogenes[25-26]. Wong et al. were able to 
detect low levels of salmonella as well as distinguish between different strains[27]. Here, the 
gold electrode layer was replaced with silver which was coated with a polyethylenimine (PEI) 
layer and crosslinked via glutaraldehyde which could be activated prior to the immobilization of 
antibodies. The use of a PEI polymer layer for antibody immobilization on a gold electrode has 
also been applied to detect rapidly detect the dengue virus from blood samples with a 100-fold 
better sensitivity than previous methods[28]. 
 
Optical waveguide sensors   
Optical waveguide structures are another choice for measuring affinity binding (see Fig. 2d). As 
in the case of SPR, measurements are based on changes in refractive-index within an evanescent 
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field region, however the design of the waveguide structure can vary greatly. One approach 
becoming prominent for biosensing, including pathogen detection, is the resonant mirror design 
supporting different resonant angles for both transverse electric (TE) and transverse magnetic 
(TM) modes[29-32]. For example, Pazos et al. utilized a resonant mirror biosensor for the detection of 
yessotoxin (YTX) by measuring the changes in the refractive index occurring when the YTX 
interacted with the ligand, phosphodiesterase, immobilized on glutaraldehyde activated 
aminosaline surface [32]. Another design example is the metal clad leaky waveguide (MCLW) 
which has a much longer penetration depth into the sample medium above the detector surface 
than the resonant mirror. In conjunction with a disposable absorbing cladding material, the LW 
biosensor could be employed to detect Bacillus subtilis var. niger (BG) bacterial spores at 10
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spores/ml as well as the sensing surface could be tailored to give a maximum extension of the 
evanescent field greater than the size of the bacteria captured by surface immobilized 
antibodies[33]. 
 
Atomic force microscopy (AFM)  
Although AFM was initially developed in the mid-1980’s, it is only after around 1995 that its use 
as a biological research tool began to flourish with improvements in instrumentation[34]. It is 
based on a very sharp probe tip, only a few nanometers thick, mounted on the end of a cantilever 
(see Figure 2e). When brought close to a surface a number of different forces can interact with 
the tip and are measured using a laser spot reflected from the top surface of the cantilever. Both 
quantitative and qualitative detection and characterization of pathogens adsorbed onto a surface 
has been achieved using tapping mode AFM which minimizes lateral or dragging force applied 
by the tip. A description of the different materials (typically glass, mica and silanized silica) 
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along with various surface chemistries for imaging the surface ultrastructure of various 
pathogens in real time has been nicely reviewed elsewhere[35]. Prominent examples include 
single virus particles such as the herpes simplex virus-1 and wild-type moloney murine leukemia, 
membrane proteins,  and the rapid visualization of capsid and DNA deposited on a mica surface 
using extra oxide-sharpened silicon nitride nanotips in tapping mode[36,37]. Though there are 
still some sensing limitations associated with mechanical complexity, tip contamination, slow 
scan speed and instrument size, prominent developments and modifications addressing these 
issues are underway ensuring AFM will feature among the next generation of biosensing 
platforms.  
 
Interferometer-based sensing   
Interferometry is a well-established optical technique that has been successfully adapted for 
label-free measurements of bioaffinity interactions. Typically, changes measured in an 
interference pattern created when a polarized light source split into a reference beam and an 
analysis beam is reflected off a surface. Changes in refractive index at the surface create 
differences in phase which is converted in an amplitude change. Among the various types of 
interferometers, Mach-Zehnder, Young’s, Hartman and backscattering configurations have been 
utilized for the detection of biomolecules including pathogens[38-40]. Ghadiri et al. 
demonstrated an approach utilizing biofunctionalized thin films of porous silicon to detect small 
molecular targets including 16-nucleotide DNA oligomers and proteins at concentrations in the 
picomolar to femtomolar range[41]. Also, in a novel approach based on a Young interferometer, 
Kanger et al. designed a chip consisting of four parallel channel waveguides connected at one 
end via a common light entry point[42]. The light emitted from the four channels at the opposite 
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end results in an interference pattern which is sensitive to refractive index changes in any one of 
the channels. A detection limit of 850 particles/mL was reported for the herpes simplex virus 
(HSV) type-1 where one of the channel surfaces was coated with a specific antibody against 
HSV with the technique easily adaptable to other targets.  
 
Emerging Technologies for Pathogen Detection  
The surface bioaffinity sensing schemes discussed in the previous section typically lack the 
sensitivity necessary for routine measurements at concentrations below the nanomolar level.  The 
continual development of new probes and their surface immobilization is important to improve 
specificity, however, will not improve sensitivity by orders of magnitude. Recently, the 
implementation of nanomaterials possessing novel optical and electrical properties has begun to 
open up many new opportunities for pathogen sensing. In this section, we highlight recent efforts 
aimed at novel signal amplification strategies based on (i) the use of biofunctionalized 
nanomaterials as an amplification tool, (ii) designing new optical and electrical based detection 
methodologies, and (iii) developing miniaturized on-chip detection systems which also integrate 
sample processing.  
 
Gold nanoparticles whose size and shape support the optical excitation of surface plasmons have 
been the most widely explored for use in various optical detection platforms[43]. Using well-
established thiol-based surface attachment chemistries, the sensitivity of the first generation 
optical sensors discussed previously can be significantly improved via a secondary amplification 
step utilizing a specific nanoparticle/probe bioconjugate. In this typical sandwich assay design 
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the presence of the nanoparticle induces large changes in the localized refractive index and if the 
operational wavelength of the sensor overlaps the nanoparticle plasmon resonance then 
additional sensitivities can be achieved[44]. Often, sensitivities greater than conventional SPR 
imaging can easily be obtained[45].  
 
Another approach involving gold nanoparticles is the design of simple colorimetric assays based 
on the controlled aggregation of a colloidal solution in the presence of a specific target. For 
example, galactose stabilized gold particles have been applied for the sensitive detection of 
ricin[46]. The use of the relatively small galactose probe promotes greater sensitivity than when 
larger probes (such as antibodies) are attached to nanoparticles which result in greater particle 
separation. In addition, nanorod shaped particles which exhibit both a transverse and 
longtitudinal surface plasmon resonance with the latter extending into the visible and near-
infrared have been shown to be more sensitive to local changes in refractive index than spheres. 
Irudayaraj et al. devised an assay for the multiplexed detection of several pathogens using 
several nanorod sizes each functionalized with an antibody specific to a different target. Both E. 
coli and S. Typhimurium were successfully detected by measuring shifts in the extinction 
spectrum in the regions associated with the longitudinal plasmon resonance[47].  
 
Beyond the use of simple adsorption/scattering based measurements, the enhanced electric field 
properties of specially designed metallic nanostructures have encouraged the exploration of a 
number of different spectroscopies for pathogen detection. Surface enhanced Raman 
spectroscopy (SERS) offers opportunities for ultrasensitive detection with the advantage of 
enabling chemical analysis and pathogen fingerprinting. However, the development of robust 
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methods for integrating SERS into reliable sensing methodologies has continued to prove 
challenging. One approach is to use reporter molecules with distinct spectra to label pathogens of 
interest. Porter et al. designed a sandwich immunoassay chip format for the detection of feline 
calcivirus[48]. Antibodies specific to the virus were immobilized on gold nanoparticles along 
with an extrinsic Raman label 5,5-dithiobis(succinimidyl-2-nitrobenzoate) and were able to 
detect less than 100 virus surface binding events.  
 
It is also possible to detect pathogens via SERS without using labels. Using a Ag nanorod array 
platform (see Figure 4A), Tripp et al. were able to uniquely indentify different viruses as well as 
differentiate between strains of the same virus[49]. Detection of the respiratory syncytial virus 
(RSV) in small (0.5-1.0 µl) volumes was identified by measuring the binding of the spike like 
glycoprotein projections on the membrane envelope through an amino group, which give rise to 
a strong band due to the C-N stretching mode. Different viral strains were characterized by 
differences in the relative intensities of peaks in the spectra due to unique pathogen surface 
proteins binding on the SERS substrate (see Figure 4B). As a result, a reference library of 
fingerprints could be established for various viruses and strains. 
 
Another example of a novel optical biosensing technology benefiting from plasmonic 
nanostructures is the development of nanoparticle-enhanced diffraction gratings (NEDG)[44, 50]. 
Here, the coupling of the optical properties of both planar surface plasmons generated on gold 
diffraction gratings and adsorbed gold nanoparticle bioconjugates are employed (see Figure 5). 
In a first demonstration, locked nucleic acid probe molecules were immobilized on the grating to 
which target microRNA sequences were first hybridized followed by a polymerase A reaction to 
15 
 
create the surface poly A tails on the grating surface. When polythymine coated gold 
nanoparticles specifically hybridized to the polyadenosine tail, the diffraction efficiency was 
measured at the first order spot, which proportionally increased as a function of the target 
concentration. The NEDG sensors initially demonstrated the detection of microRNA and DNA at 
concentrations as low as 10 fM ranges[44, 50]. We envision that NEDG sensors possess hold 
significant potential for a wide range of applications including the highly sensitive detection of 
pathogens as well as other biological molecules. 
 
In addition to surface sensitive optical sensors involving nanomaterials, electrochemical 
detection is an excellent alternative since electrical signals can be greatly amplified and multi-
nano electrode platforms have the potential for high throughput detection. For example, 
electrochemical immunoassays using interdigitated nanostructured silicon transducers have been 
demonstrated for the rapid discrimination of live pathogens versus harmless dead ones[51]. This 
was achieved using a pair of interdigitated polycrystalline silicon electrodes whose surface was 
coated by thin layer of native silicon oxide upon which antibody probes were immobilized. 
Impedance spectra were measured at a high frequency range along with changes in the 
capacitance caused by the interaction of the live bacteria with supporting AFM measurements 
used to image bacterial cells. In another example, lithographically fabricated silicon nanowire 
transistors featuring 50 nm polysilicon nanowires connected with gold electrodes spaced 150 nm 
apart and a 200-500 nm polyimide insulating layer (see Figure 6a) have been developed for the 
ultra sensitive detection of the bacterial toxin, staphylococcus aureus enterotoxin B (SEB), at 
femtomolar concentrations[52]. As shown in Figure 6, the charge transfer resistances associated 
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with the mass transfer of SEB complexed with the anti-SEB on the nanowire electrode 
proportionally increased with the SEB concentration. The In2O3 nanowire FETs sensing platform 
was further developed for the detection of severe acute respiratory syndrome (SARS) virus by 
means of measuring the interaction of a biomarker associated with the SARS corona virus with 
the antibody mimic proteins immobilized on the nanowire surface[53].  
 
Other types of nanomaterials besides metallic structures have also been applied to pathogen 
sensing. For example, peptide nanotubes were designed for the detection of viruses such as 
herpes simplex virus type 2, adenovirus, vaccinia and influenza type B at attomolar 
sensitivities[54]. The peptide nanotubes were functionalized with antibodies at their ends and 
fluorescent signaling units on their sidewalls. When viral pathogens were mixed with these 
antibody-coated nanotubes, the nanotubes rapidly aggregated around the viruses to form a 
networked structure. The size of the aggregates increased with the concentration of viruses and 
detected via flow cytometry by measuring forward light scattering intensity and fluorescence 
intensity of aggregated dye-loaded antibody nanotubes around viruses. 
 
Finally, another emerging area we want to highlight is the promise of portable, rapid and highly 
sensitive diagnostic microchip based devices incorporating microfluidics alongside miniaturized 
electronics, optical elements, fluid handling components and data acquisition software[55]. The 
“lab-on-a-chip” concept involving a fully integrated system offers several advantages such as 
requiring very small amounts of sample, high precision, shortened analysis times and good 
reproducibility. With respect to pathogen detection most recent advances in this area have 
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focused on the challenge of incorporating conventional PCR based technologies[56];  for 
example, an integrated PCR–capillary electrophoresis chip[57]. One highlight is the combined 
use of the optothermal properties of gold nanorods in a microfluidic chip device along with a 
one-step real-time PCR system[58]. The longitudinal resonance of gold nanorods was used to 
transform near infrared energy into thermal energy resulting in effective on-chip pathogen lysis. 
The DNA extracted out of the E. coli BL21 cell body was transferred to a real-time PCR 
chamber for amplified detection without additional sample processing. Another interesting 
approach worth mentioning is the design of a complete integrated chip-based system (see Figure 
7a) for the ultra-sensitive detection of avian influenza virus H5N1[59]. The sample viral RNA is 
first isolated, purified and preconcentrated using silica-coated superparamagnetic particles before 
undergoing RT-PCR on a miniaturized thermocycler. As depicted in Figure 7b, each step was 
performed in droplets on a Teflon coated disc manipulated under a controlled magnetic field. In 
particular, PCR was achieved within 30 minutes by moving the droplet clockwise over different 
temperature zones which was monitored in real time with fluorescence-based detection utilizing 
an integrated optical system. In addition to on-chip PCR devices, microchannels filled with a 
photopolymerized crosslinked polyacrylamide gel were developed to achieve improved 
elecctrophoretic separation of the antibody-analyte complex from excess antibody. The ratio of 
bound versus unbound immune-complexes in the microchannel was then measured by laser-
induced fluorescence. The rapid detection of SEB, shiga toxin I and ricin at picomolar 
concentrations using minimal sample volumes (<10 µl) was achieved in 20 minutes[60].  
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Conclusions/Outlook 
Of the various sensing methodologies described here, optical-based surface-sensitive techniques 
currently remain the most promising for ultrasensitive high throughput pathogen detection. The 
introduction of new nanomaterials and lab-on-a-chip concepts has been shown to significantly 
advance current biosensing technologies in terms of sensitivity, disposability and cost-
effectiveness. The ideal technique will be able to simultaneously monitor multiple targets 
directly in complex environments with minimum or no prior sample preparation and have a large 
measurement dynamic range from subfemtomolar to nanomolar concentrations. Furthermore, 
new sensing technologies should be capable of not only detecting the presence of a particular 
pathogen but also assessing its bioactivity to determine whether the pathogen is in an active state. 
This requires continual advances in both the design and availability of biomolecular probes 
specific to a wide range of targets along with improvements in surface chemistries which 
eliminate issues such as non-specific adsorption irrespective of sample type or complexity. Due 
to the continual demand for improved pathogen sensing, this field will remain at the forefront of 
development as one of the first applications with which to assess the performance of next 
generation sensors. We envision that development of new optical sensing techniques utilizing 
nanomaterials integrated within complete lab-on-a-chip platforms will feature prominently in the 
near future as this exciting area of research continues to rapidly develop.  
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Figure Captions 
Figure 1.  Timeline describing the development of pathogen detection methods. 
 
Figure 2.  Schematic overview of surface-based optical detection platforms for pathogen 
detection; (a) fluorescence microscopy, (b) surface plasmon resonance (SPR), (c) quartz crystal 
microbalance (QCM), (d) optical waveguide sensors and (e) atomic force microscopy (AFM).  
 
Figure 3.  Schematic of SPR imaging set-up with the inset showing a representative SPR 
difference  image showing the hybridization adsorption of 2 nM 16S rRNA from E. coli onto a 
three-component DNA array. The array element C is the 25mer DNA probe sequence 
complementary to E coli RNA. Inset data is adapted with permission from ref. 21. 
 
Figure 4.  (A) Schematic diagram showing the detection of respiratory virus based on surface 
enhanced  Raman scattering (SERS) using silver nanorod array substrates. (B) SERS spectra 
showing a) uninfected vero cell lysate, b) RSV-infected cell lysate and c) purified RSV. 
Distinctive spectral bands assigned at 1066 cm-
1 
 (C-N stretch), 835 cm
-1
 (tyrosine), and a 
doublet at 545 cm
-1 
and 523 cm
-1
 (S-S) appear in the RSV infected cell lysate samples but not in 
the uninfected cell lysates. Adapted with permission from ref. 49. 
 
Figure 5.  Schematic of nanoparticle enhanced diffraction grating setup for the detection of 
pathogens using various probes including aptamers, antibodies and short oligomers immobilized 
on gold line grating surfaces. Biofunctionalized gold nanoparticles (incl. nanorods) can be 
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utilized to enhance the diffraction signal in a sandwich format where the surface probe interacts 
with the target pathogen followed by the recognition of biomolcules coated on the nanomaterials. 
Briefly, p-polarized white light through a narrowband pass filter is impinged onto a prism/grating 
chip/flow cell assembly at a fixed incidence angle. Next, either the +1, 0 and −1 orders can then 
be imaged on a CCD camera or the +1 diffraction beam can be passed through a lens and 
detected using an avalanche photodiode (APD). The left bottom inset is the 3D image of the +1, 
0, −1 orders. The right inset is a representative TEM image of gold nanorods with peak maxima 
at 510 nm and 720 nm.  
 
Figure 6.  (a) Schematic depicting an In2O3  nanowire device for SARS virus detection. The 
nanowire was functionalized with Fn probes which can specifically bind the target N protein. 
Bovine serum albumin (BSA) was used to prevent any nonspecific binding events. (b) Response 
curve for the N protein interacting with the Fn probe molecules immobilized on the surface of 
nanowire device. The arrows are the times when a given concentration of N protein solution was 
injected. The inset on the left side is to show the plateau and the definition of response time. 
Adapted with permission from ref. 53. 
 
Figure 7.  Schematics showing (a) the arrangement of droplets on a PCB printed circuit board, 
and (b) droplet manipulation using magnetic forces through a series of processes on a 
perfluorinated surface.  G is the perfluorinated glass substrate, M is the permanent magnet, T is 
the miniaturized thermocycler indicating one of four donut-shaped circles, Sa is the raw sample 
solution spiked with in vitro transcribed HPAI H5N1 RNA including lysis/binding/enhancer 
21 
 
solution and silica particles, W1 and W2 are the washing solution 1 and 2, R is the RT-PCR 
mixture covered by mineral oil. Adapted with permission from ref. 59. 
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Table 1.  Summary of various surface bioaffiinity sensing methods applied to a wide range of 
pathogens along with the type of surface probe used and the reported detection limit. 
 
 
 
Technology 
Platform 
Target Pathogens Surface Probes Detection Limit Ref. 
Fluorescence 
microscopy 
Staphylococcal enterotoxin B  Antibody 10
3
-10
6
 cfu/mL [10] 
 Campylobacter jejuni Antibody 500-3780 cfu/mL [12] 
 Salmonella typhi Porphyrin 10
2
 cells [13] 
 Dengue Antibody 15 pmol/L [61] 
SPR Escherichia coli (E. coli ) 
O157:H7 
Antibody 10
3
 cfu/mL [17] 
 Bacillus anthracis Antibody 10
4
 cfu/mL [20] 
 Fusarium culmorum Oligonucleotide 0.06 pg/30 ng [62] 
 E. coli  Oligonucleotide 2 nM [21] 
 Brucella abortus, E. coli,  
Staphylococcus  aures  
Oligonucleotide 100 pM [22] 
QCM Listeria monocitogenes Antibody 10
7
 cells/mL [26] 
 Salmonella Antibody 10
4
 cells/mL [27] 
 Dengue Antibody 5 µg/mL [28] 
Optical 
waveguide 
Staphylococcus aures Protein 4x10
3
-1.6x10
6 
cells/mL [29] 
 Yessotoxin Enzyme 3.85 µM [32] 
 Bacillus globigii Antibody 10
7 
spores/mL [33] 
AFM Herpes simplex virus -- Single virus particle [36] 
 Moloney murine leukemia virus Antibody 11-14 cells [37] 
 Human immunodeficiency virus- 
type 1 
Antibody 25 fg/mL [63] 
Interferometer Salmonella typhimurium Antibody 1x10
4
 cfu/mL [40] 
 Herpes simplex virus type 1 Antibody 850 particles/mL [42] 
SERS Feline calicivirus  Antibody 1x10
6 
viruses/mL [48] 
 Respiratory syncytial virus  -- 100 pfu/mL [49] 
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